{"id":1028,"date":"2026-07-25T10:25:34","date_gmt":"2026-07-25T10:25:34","guid":{"rendered":"https:\/\/genes2me.com\/blog\/?p=1028"},"modified":"2026-07-25T10:33:13","modified_gmt":"2026-07-25T10:33:13","slug":"cliseq-interpreter-clinical-genomics-software","status":"publish","type":"post","link":"https:\/\/genes2me.com\/blog\/cliseq-interpreter-clinical-genomics-software\/","title":{"rendered":"From Reads to Reporting: Solving the NGS Bottleneck with CliSeq Interpreter"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" width=\"1024\" height=\"449\" src=\"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/07\/cliseq-02-02-5-1024x449.jpg\" alt=\"clinical genomics interpretation software\" class=\"wp-image-1041\" srcset=\"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/07\/cliseq-02-02-5-1024x449.jpg 1024w, https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/07\/cliseq-02-02-5-300x131.jpg 300w, https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/07\/cliseq-02-02-5-768x336.jpg 768w, https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/07\/cliseq-02-02-5-1536x673.jpg 1536w, https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/07\/cliseq-02-02-5-2048x897.jpg 2048w, https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/07\/cliseq-02-02-5-769x337.jpg 769w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>In the rapidly evolving landscape of clinical genomics, next-generation sequencing (NGS) has achieved remarkable milestones on the wet-lab side. High-precision, target-enriched panels\u2014such as the <strong>Genes2Me <a href=\"https:\/\/www.genes2me.com\/ngs\/oncology\/pan-cancer-testing-panel\">PanCan Cancer Genomic Profiling (CGP) Assay<\/a><\/strong>\u2014and advanced automated library preparation systems, like the <strong>EZY AutoPrep-48<\/strong>, have dramatically simplified sample processing. Clinical labs can now isolate nucleic acids and prepare sequence-ready libraries with minimal hands-on time.<\/p>\n\n\n\n<p>However, as sequencing capacity grows, laboratories worldwide are colliding with the silent and formidable <strong>dry-lab bottleneck. <\/strong>This is where G2M&#8217;s <strong>CliSeq Interpreter<\/strong> is closing the gap between<strong> &#8220;data generated&#8221; and &#8220;life saved.&#8221;<\/strong><\/p>\n\n\n\n<p>Here\u2019s a scene playing out in clinical labs around the world: The sequencer has finished its run. The wet lab team did everything right\u2014clean extraction, flawless library prep, and a beautiful run on the flow cell. Gigabytes of raw (FASTQ) data are sitting on a server. Historically, converting this complex genomic data into an actionable report required a dedicated team of scarce, high-cost bioinformaticians, expensive on-premise CPU servers, and hours\u2014or even days\u2014of manual curation.<\/p>\n\n\n\n<p>To solve this operational crisis and fulfill the true promise of precision medicine, <strong><a href=\"https:\/\/www.genes2me.com\/\">Genes2Me (G2M)<\/a><\/strong> has engineered the <strong><a href=\"https:\/\/www.genes2me.com\/instruments\/client-staging-genesreport\">CliSeq Interpreter<\/a><\/strong>\u2014an automated, cloud-based clinical interpretation companion platform designed to turn complex sequencing data into life-saving clinical insights in minutes. Fine-tuned for organizational efficiency, it is built on:<\/p>\n\n\n\n<h3><a><\/a>1. GPU-Accelerated Architecture for Rapid Turnaround<\/h3>\n\n\n\n<p>CliSeq Interpreter features a specialized Linux-based, <strong>GPU-accelerated hardware architecture<\/strong> that slashes processing times to a fraction of the industry average. By parallelizing alignment and variant-calling calculations, the platform enables clinical pathology labs to compress their dry-lab timeline from days to minutes, ensuring that life-saving therapeutic decisions can be reached without delay.<\/p>\n\n\n\n<h3><a><\/a>2. Platform-Agnostic Fluidity<\/h3>\n\n\n\n<p>To provide modern laboratories with complete operational freedom, CliSeq Interpreter is built to be entirely platform-agnostic. Think of it as the automated brain sitting between your sequencer and your final report\u2014no coding required, built for pathologists, lab techs, and oncologists to run directly. <strong>It&#8217;s fast, on purpose, and it doesn&#8217;t care what sequencer you have:<\/strong><\/p>\n\n\n\n<ul><li><strong>Illumina<\/strong> (e.g., NovaSeq, MiSeq)<\/li><li><strong>Thermo Fisher Scientific<\/strong> (Ion Torrent)<\/li><li><strong>MGI Tech<\/strong><\/li><li><strong>Element Biosciences<\/strong><\/li><\/ul>\n\n\n\n<p><strong>It goes deep, not just fast.<\/strong> Behind the scenes, it runs a full three-stage pipeline:<\/p>\n\n\n\n<ul><li><strong>Primary analysis\u2014QC, adapter trimming, and alignment, with Q30 scores above 90% <\/strong>and coverage uniformity above 99%.<\/li><li><strong>Secondary analysis\u2014<\/strong>Variant calling sensitive enough to catch VAFs as low as 1\u20135% at better than<strong> 98.9% sensitivity<\/strong>. <strong>SNVs, InDels, CNVs, structural variants, fusions, plus TMB, MSI, and HRD scoring.<\/strong><\/li><li><strong>Tertiary analysis<\/strong> \u2014 the part that turns data into medicine. Variants get mapped against <strong>ClinVar, OMIM, COSMIC, and HPO<\/strong>, then classified under <strong>ACMG, AMP, NCCN, and ASCO guidelines,<\/strong> and matched to <strong>FDA-approved therapies<\/strong>, resistance mechanisms, and active clinical trials.<\/li><\/ul>\n\n\n\n<p>What comes out the other end is a clinician-ready Clinically Significant Mutation (CSM) Report \u2014 PDF and Excel \u2014 that a pathologist can sign and an oncologist can act on the same day.<\/p>\n\n\n\n<h2><a><\/a>Built to be trusted with the data that matters most<\/h2>\n\n\n\n<p>Genomic data is about as sensitive as data gets, so CliSeq runs on regional AWS infrastructure built to meet GDPR, HIPAA, and local data sovereignty requirements. For labs that need to show their work, there&#8217;s also a built-in Genewise Coverage Utility that generates gene- and location-level coverage metrics\u2014the kind of documentation that makes audits and validations far less painful.<\/p>\n\n\n\n<h2><a><\/a>The part we&#8217;re genuinely proud of<\/h2>\n\n\n\n<p>Here&#8217;s where we do things differently. A lot of the industry treats interpretation software as its own profit center\u2014tens of thousands of dollars a year in licensing, seat fees, and per-sample charges stacked on top of the assay itself. At exactly the moment labs are under pressure to move from RUO to CE-IVD workflows while reimbursement rates shrink, that math doesn&#8217;t work for anyone.<\/p>\n\n\n\n<p>So we don&#8217;t do it that way. If your lab runs our PanCan CGP assay, our clinical exome panels, or the <a href=\"https:\/\/www.genes2me.com\/ngs\/blood-cancer\/hemat-ngs-assay\">Hemat NGS assay<\/a>, CliSeq Interpreter comes with it. No hidden fees, no per-sample tax on interpretation.<\/p>\n\n\n\n<p>We&#8217;d rather build software that removes a barrier to precision medicine than software that becomes one.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In the rapidly evolving landscape of clinical genomics, next-generation sequencing (NGS) has achieved remarkable milestones on the wet-lab side. High-precision, target-enriched panels\u2014such as the Genes2Me&hellip;<\/p>\n","protected":false},"author":1,"featured_media":1038,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1,214],"tags":[488,491,489,490],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>CliSeq Interpreter: AI-Powered Clinical Genomics Software<\/title>\n<meta name=\"description\" content=\"Turn raw sequencing data into clinician-ready reports in minutes. CliSeq Interpreter automates variant calling, annotation &amp; CSM reporting. Learn more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genes2me.com\/blog\/cliseq-interpreter-clinical-genomics-software\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CliSeq Interpreter: AI-Powered Clinical Genomics Software\" \/>\n<meta property=\"og:description\" content=\"Turn raw sequencing data into clinician-ready reports in minutes. CliSeq Interpreter automates variant calling, annotation &amp; CSM reporting. Learn more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genes2me.com\/blog\/cliseq-interpreter-clinical-genomics-software\/\" \/>\n<meta property=\"og:site_name\" content=\"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-25T10:25:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-25T10:33:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/07\/cliseq-02-02-4.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"700\" \/>\n\t<meta property=\"og:image:height\" content=\"525\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Genes2Me\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Genes2Me\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/genes2me.com\/blog\/#organization\",\"name\":\"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems\",\"url\":\"https:\/\/genes2me.com\/blog\/\",\"sameAs\":[],\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/genes2me.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2023\/09\/cropped-G2M150x150.jpg\",\"contentUrl\":\"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2023\/09\/cropped-G2M150x150.jpg\",\"width\":150,\"height\":69,\"caption\":\"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems\"},\"image\":{\"@id\":\"https:\/\/genes2me.com\/blog\/#\/schema\/logo\/image\/\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/genes2me.com\/blog\/#website\",\"url\":\"https:\/\/genes2me.com\/blog\/\",\"name\":\"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems\",\"description\":\"Real Time PCR Molecular Diagnostics NGS Cancer Screening Sequencing COVID-19 Rapid Antigen Antibody Made in India Manufacturer Clinical\/Whole Exome\",\"publisher\":{\"@id\":\"https:\/\/genes2me.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/genes2me.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/genes2me.com\/blog\/cliseq-interpreter-clinical-genomics-software\/\",\"url\":\"https:\/\/genes2me.com\/blog\/cliseq-interpreter-clinical-genomics-software\/\",\"name\":\"CliSeq Interpreter: AI-Powered Clinical Genomics Software\",\"isPartOf\":{\"@id\":\"https:\/\/genes2me.com\/blog\/#website\"},\"datePublished\":\"2026-07-25T10:25:34+00:00\",\"dateModified\":\"2026-07-25T10:33:13+00:00\",\"description\":\"Turn raw sequencing data into clinician-ready reports in minutes. CliSeq Interpreter automates variant calling, annotation & CSM reporting. Learn more.\",\"breadcrumb\":{\"@id\":\"https:\/\/genes2me.com\/blog\/cliseq-interpreter-clinical-genomics-software\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/genes2me.com\/blog\/cliseq-interpreter-clinical-genomics-software\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/genes2me.com\/blog\/cliseq-interpreter-clinical-genomics-software\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/genes2me.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"From Reads to Reporting: Solving the NGS Bottleneck with CliSeq Interpreter\"}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/genes2me.com\/blog\/cliseq-interpreter-clinical-genomics-software\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/genes2me.com\/blog\/cliseq-interpreter-clinical-genomics-software\/\"},\"author\":{\"name\":\"Genes2Me\",\"@id\":\"https:\/\/genes2me.com\/blog\/#\/schema\/person\/10206ca125f3a19893d76130599c48aa\"},\"headline\":\"From Reads to Reporting: Solving the NGS Bottleneck with CliSeq Interpreter\",\"datePublished\":\"2026-07-25T10:25:34+00:00\",\"dateModified\":\"2026-07-25T10:33:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/genes2me.com\/blog\/cliseq-interpreter-clinical-genomics-software\/\"},\"wordCount\":682,\"publisher\":{\"@id\":\"https:\/\/genes2me.com\/blog\/#organization\"},\"keywords\":[\"clinical genomics\",\"CliSeq Interpreter\",\"NGS interpretation software\",\"precision medicine platform\"],\"articleSection\":[\"Dignostic Solution\",\"NGS Assays\"],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/genes2me.com\/blog\/#\/schema\/person\/10206ca125f3a19893d76130599c48aa\",\"name\":\"Genes2Me\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/genes2me.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d657e6ab646ef1896bc855e2b96e924e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d657e6ab646ef1896bc855e2b96e924e?s=96&d=mm&r=g\",\"caption\":\"Genes2Me\"},\"description\":\"Established in 2016, Genes2Me is a leading molecular diagnostics company committed to transforming healthcare through innovative, high-quality in vitro diagnostic (IVD) solutions. Built on a strong foundation of scientific excellence and precision engineering, Genes2Me develops and manufactures advanced diagnostic technologies that enable accurate, reliable, and timely clinical decision-making across diverse healthcare settings worldwide. With a comprehensive and rapidly expanding portfolio, Genes2Me offers cutting-edge solutions across molecular diagnostics, including Next Generation Sequencing (NGS) clinical assays, point-of-care (POC) testing platforms, RT-PCR kits and instruments, as well as nucleic acid extraction kits and automation systems. Designed to meet the evolving needs of modern laboratories and clinicians, our products combine performance, scalability, and operational efficiency. A vast majority of Genes2Me products are CE-IVD marked, reflecting our commitment to global quality benchmarks, regulatory compliance, and uncompromising product standards. At the heart of our innovation are proprietary platforms such as OnePCR and Rapi-Q, developed to deliver rapid, multiplex, and highly sensitive molecular detection with streamlined workflows and minimal turnaround time. OnePCR integrates automated nucleic acid extraction and RT-PCR into a single, seamless workflow, enabling the detection of up to 20 targets from a single sample with exceptional precision and efficiency. The Rapi-Q series is engineered for fast, sensitive, and multiplex testing with a larger throughput, empowering healthcare providers with timely diagnostic insights that support improved patient outcomes. In genomics, Genes2Me offers one of the industry\u2019s most comprehensive NGS clinical assay portfolios, spanning oncology, liquid biopsy, whole exome sequencing, NIPT and pharmacogenomics. Complementing this portfolio is EZY AutoPrep, our advanced automated library preparation workstation designed to optimize NGS library preparation through enhanced accuracy, reproducibility, and scalability. Our genomics ecosystem is further strengthened by CliSeq Interpreter, a cloud-based bioinformatics platform that enables accurate, flexible, and intuitive interpretation of complex genomic data, helping laboratories generate high-confidence insights with efficiency and ease. Driven by innovation, quality, and a global vision, Genes2Me continues to redefine the future of molecular diagnostics\u2014delivering integrated solutions that advance precision medicine and improve lives worldwide.\",\"sameAs\":[\"https:\/\/www.genes2me.com\/\"],\"url\":\"https:\/\/genes2me.com\/blog\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CliSeq Interpreter: AI-Powered Clinical Genomics Software","description":"Turn raw sequencing data into clinician-ready reports in minutes. CliSeq Interpreter automates variant calling, annotation & CSM reporting. Learn more.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genes2me.com\/blog\/cliseq-interpreter-clinical-genomics-software\/","og_locale":"en_US","og_type":"article","og_title":"CliSeq Interpreter: AI-Powered Clinical Genomics Software","og_description":"Turn raw sequencing data into clinician-ready reports in minutes. CliSeq Interpreter automates variant calling, annotation & CSM reporting. Learn more.","og_url":"https:\/\/genes2me.com\/blog\/cliseq-interpreter-clinical-genomics-software\/","og_site_name":"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems","article_published_time":"2026-07-25T10:25:34+00:00","article_modified_time":"2026-07-25T10:33:13+00:00","og_image":[{"width":700,"height":525,"url":"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/07\/cliseq-02-02-4.jpg","type":"image\/jpeg"}],"author":"Genes2Me","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Genes2Me","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Organization","@id":"https:\/\/genes2me.com\/blog\/#organization","name":"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems","url":"https:\/\/genes2me.com\/blog\/","sameAs":[],"logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/genes2me.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2023\/09\/cropped-G2M150x150.jpg","contentUrl":"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2023\/09\/cropped-G2M150x150.jpg","width":150,"height":69,"caption":"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems"},"image":{"@id":"https:\/\/genes2me.com\/blog\/#\/schema\/logo\/image\/"}},{"@type":"WebSite","@id":"https:\/\/genes2me.com\/blog\/#website","url":"https:\/\/genes2me.com\/blog\/","name":"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems","description":"Real Time PCR Molecular Diagnostics NGS Cancer Screening Sequencing COVID-19 Rapid Antigen Antibody Made in India Manufacturer Clinical\/Whole Exome","publisher":{"@id":"https:\/\/genes2me.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genes2me.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/genes2me.com\/blog\/cliseq-interpreter-clinical-genomics-software\/","url":"https:\/\/genes2me.com\/blog\/cliseq-interpreter-clinical-genomics-software\/","name":"CliSeq Interpreter: AI-Powered Clinical Genomics Software","isPartOf":{"@id":"https:\/\/genes2me.com\/blog\/#website"},"datePublished":"2026-07-25T10:25:34+00:00","dateModified":"2026-07-25T10:33:13+00:00","description":"Turn raw sequencing data into clinician-ready reports in minutes. CliSeq Interpreter automates variant calling, annotation & CSM reporting. Learn more.","breadcrumb":{"@id":"https:\/\/genes2me.com\/blog\/cliseq-interpreter-clinical-genomics-software\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genes2me.com\/blog\/cliseq-interpreter-clinical-genomics-software\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/genes2me.com\/blog\/cliseq-interpreter-clinical-genomics-software\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/genes2me.com\/blog\/"},{"@type":"ListItem","position":2,"name":"From Reads to Reporting: Solving the NGS Bottleneck with CliSeq Interpreter"}]},{"@type":"Article","@id":"https:\/\/genes2me.com\/blog\/cliseq-interpreter-clinical-genomics-software\/#article","isPartOf":{"@id":"https:\/\/genes2me.com\/blog\/cliseq-interpreter-clinical-genomics-software\/"},"author":{"name":"Genes2Me","@id":"https:\/\/genes2me.com\/blog\/#\/schema\/person\/10206ca125f3a19893d76130599c48aa"},"headline":"From Reads to Reporting: Solving the NGS Bottleneck with CliSeq Interpreter","datePublished":"2026-07-25T10:25:34+00:00","dateModified":"2026-07-25T10:33:13+00:00","mainEntityOfPage":{"@id":"https:\/\/genes2me.com\/blog\/cliseq-interpreter-clinical-genomics-software\/"},"wordCount":682,"publisher":{"@id":"https:\/\/genes2me.com\/blog\/#organization"},"keywords":["clinical genomics","CliSeq Interpreter","NGS interpretation software","precision medicine platform"],"articleSection":["Dignostic Solution","NGS Assays"],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/genes2me.com\/blog\/#\/schema\/person\/10206ca125f3a19893d76130599c48aa","name":"Genes2Me","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/genes2me.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d657e6ab646ef1896bc855e2b96e924e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d657e6ab646ef1896bc855e2b96e924e?s=96&d=mm&r=g","caption":"Genes2Me"},"description":"Established in 2016, Genes2Me is a leading molecular diagnostics company committed to transforming healthcare through innovative, high-quality in vitro diagnostic (IVD) solutions. Built on a strong foundation of scientific excellence and precision engineering, Genes2Me develops and manufactures advanced diagnostic technologies that enable accurate, reliable, and timely clinical decision-making across diverse healthcare settings worldwide. With a comprehensive and rapidly expanding portfolio, Genes2Me offers cutting-edge solutions across molecular diagnostics, including Next Generation Sequencing (NGS) clinical assays, point-of-care (POC) testing platforms, RT-PCR kits and instruments, as well as nucleic acid extraction kits and automation systems. Designed to meet the evolving needs of modern laboratories and clinicians, our products combine performance, scalability, and operational efficiency. A vast majority of Genes2Me products are CE-IVD marked, reflecting our commitment to global quality benchmarks, regulatory compliance, and uncompromising product standards. At the heart of our innovation are proprietary platforms such as OnePCR and Rapi-Q, developed to deliver rapid, multiplex, and highly sensitive molecular detection with streamlined workflows and minimal turnaround time. OnePCR integrates automated nucleic acid extraction and RT-PCR into a single, seamless workflow, enabling the detection of up to 20 targets from a single sample with exceptional precision and efficiency. The Rapi-Q series is engineered for fast, sensitive, and multiplex testing with a larger throughput, empowering healthcare providers with timely diagnostic insights that support improved patient outcomes. In genomics, Genes2Me offers one of the industry\u2019s most comprehensive NGS clinical assay portfolios, spanning oncology, liquid biopsy, whole exome sequencing, NIPT and pharmacogenomics. Complementing this portfolio is EZY AutoPrep, our advanced automated library preparation workstation designed to optimize NGS library preparation through enhanced accuracy, reproducibility, and scalability. Our genomics ecosystem is further strengthened by CliSeq Interpreter, a cloud-based bioinformatics platform that enables accurate, flexible, and intuitive interpretation of complex genomic data, helping laboratories generate high-confidence insights with efficiency and ease. Driven by innovation, quality, and a global vision, Genes2Me continues to redefine the future of molecular diagnostics\u2014delivering integrated solutions that advance precision medicine and improve lives worldwide.","sameAs":["https:\/\/www.genes2me.com\/"],"url":"https:\/\/genes2me.com\/blog\/author\/admin\/"}]}},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/posts\/1028"}],"collection":[{"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/comments?post=1028"}],"version-history":[{"count":3,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/posts\/1028\/revisions"}],"predecessor-version":[{"id":1043,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/posts\/1028\/revisions\/1043"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/media\/1038"}],"wp:attachment":[{"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/media?parent=1028"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/categories?post=1028"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/tags?post=1028"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}